CODX vs EMN · rev $3.9M vs P/E 21, rev $9.38B
Co-Diagnostics, Inc. Common Stock (CODX) versus Eastman Chemical Company (EMN) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Eastman Chemical Company (EMN) is a specialty chemicals company listed on US.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported EMN revenue for 2024-12-31 was $9.38B. Net income was $908.0M. Revenue was up 1.9% from 2023-12-31 to 2024-12-31. EMN currently screens at market cap $8.21B and trailing P/E 20.8.
CODX currently screens at market cap $31.4M. EMN currently screens at market cap $8.21B and trailing P/E 20.8.
Not investment advice. Open the CODX and EMN stock pages for the full models.
Not investment advice.